Expert advice on how all members of the primary are team can improve detection of patients at risk of lung cancer is set out in a new suite of articles published by PCRS.

PCRS offer two posters available for download and use in practice surgeries and pharmacies.  The posters highlight the benefit of regular preventer inhaler therapy and a reduction in reliance on short -acting reliever inhalers.  Both posters recommend talking to the practice nurse or ph

In this article, updated for asthma in November 2019, we discuss the building blocks of a good asthma review focusing on:

Case Study 1 - Noel Baxter Locum GP and PCRS Policy Lead discusses the importance of system change in the practice particularly around the reviewing and re-authorising of repeat prescriptions for short acting beta-2-agonsts

The playing cards on these slides and downloadable PDF playing cards are a way to trigger conversations with healthcare teams, and between pharmacists and patients regarding the use of/reliance on SABA inhalers. We invite you to use them to start a discussion!

In this article for Primary Care Respiratory Academy, Noel Baxter describes the nine good care processes developed by a multidisciplinary and integrated respiratory team in Lambeth and Southwark with a novel way to disseminate the measures and show improvement.

NICE and Public Health England have published new antimicrobial prescribing guidance on

The least cost-effective inhaler device is the one that the patient cannot use. In deciding which device and drug formulation to prescribe healthcare professionals should first determine the patient’s ability to use the prescribed device correctly.

Fran Robinson talks to a patient who has had asthma all her life, feels that annual asthma reviews are a waste of time (except when they are conducted by PCRS members).

Key facts

E-cigarettes have become increasingly popular in recent years. The main reason given by current vapers for using e-cigarettes is to help them stop smoking tobacco. This pragmatic article provides information on the safety and effectiveness of e-cigarettes as a stop smoking tool.

If you are confused by conflicting guidance on the role of FeNO testing in the diagnosis of asthma, take a look at the new PCRS consensus statement which gives pragmatic advice on when FeNO testing in primary care should be co

The exhaled carbon monoxide (CO) test detects exposure to CO in the last 12-18 hours. This can be used to assess smoking status AFTER a quit attempt and used prior to a quit attempt as a motivational tool.

Alongside a detailed clinical history and other important tests to assess variability (peak flow, reversibility and challenge tests) it is used to support the diagnosis of asthma. PCRS has produced this consensus position on the use of FeNO in primary care to support the diagnosis of as

Q: My patient smokes cigarettes and has a BMI of 43, they drink 45 units of alcohol a week and their physical activity is limited. What should I do first or is it better to tackle all together?